Dr. Aferdita Spahillari
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Tufts University School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 351
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: Tufts University School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
MA license 255680 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Duke University Hospital Durham, NC
- Novant Health New Hanover Regional Medical Center Wilmington, NC
Medical groups
- Duke Health Integrated Practice, Inc (3,185 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 351
- Services billed
- 1,338
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | 233 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 134 | 57 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 114 | 45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 102 | 87 |
| Established patient office or other outpatient visit, 40-54 minutes | 75 | 69 |
| Evaluation of lower heart chamber assist device | 74 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 67 | 62 |
| Critical care, first 30-74 minutes | 44 | 15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | 42 |
| Interpretation and report of ultrasound of heart | 37 | 37 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Boston, MA | 111 |
| Entresto (sacubitril/valsartan) Other prescribers in Boston, MA | 104 |
| Metoprolol Succinate Other prescribers in Boston, MA | 68 |
| Jardiance (empagliflozin) Other prescribers in Boston, MA | 61 |
| Furosemide Other prescribers in Boston, MA | 61 |
| Torsemide Other prescribers in Boston, MA | 32 |
| Carvedilol Other prescribers in Boston, MA | 31 |
| Losartan Potassium Other prescribers in Boston, MA | 27 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Boston, MA | 24 |
| Eliquis (apixaban) Other prescribers in Boston, MA | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 2 payments worth $7.07 in total to this clinician.
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $7.07 |
|---|
| Food and Beverage | $7.07 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $2,100 in research payments for these studies, mostly to the institutions running them.
- Dapagliflozin in Acute Decompensated Heart Failure
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.